临床试验/NCT07447518

NCT07447518已完成1 期

Comparison of Mirabegron ,Tamsulosin and Solifenacinin Relieving Double -J Stent Related Symptoms : Approspective Randmized Placebo Controlledtrial

Kafrelsheikh University1 个研究点分布在 1 个国家目标入组 535 人开始时间: 2022年9月22日最近更新: 2026年3月3日

干预措施

试验速览

阶段: 1 期
状态: 已完成
发起方: Kafrelsheikh University
入组人数: 535
试验地点: 1
主要终点: Double j related symptoms

研究概览研究设计入排标准研究组 & 干预措施结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

In urology, ureteral stents are used to treat obstructive diseases. Hematuria (54%), fever, discomfort, and lower urinary system symptoms are the predominant symptoms related to ureteral stent.

研究设计

研究类型: Interventional
分配方式: Randomized
干预模型: Parallel
主要目的: Supportive Care
盲法: None

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•age above 18 years
•any patient need post urs or pcnl double stent

排除标准

•age less than 18 years
•known over active bladder patient

研究组 & 干预措施

Group A : patients will receive tadalafil

Active Comparator

干预措施: Tadalafil 5mg (Drug)

Group B: patients will receive solidosin

Active Comparator

干预措施: solidosin (Drug)

Group C: patients will receive solfenacin

Active Comparator

干预措施: Solfenacin (Drug)

Group D: patients will receive mirabegron

Active Comparator

干预措施: Mirabegron (Drug)

Group E: patients will receive placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Double j related symptoms

时间窗: Six weeks

Double j related symptoms questionnaire score

次要结局

Sex matters related double j stent(Six weeks)

研究者

发起方

Kafrelsheikh University

申办方类型

Other

责任方

Principal Investigator

主要研究者

Elsayed Abdelhalim Elsayed

assistant lecturer, urology department, Kafrelsheikh university

Kafrelsheikh University

研究点 (1)

Loading locations...

相似试验

已完成

不适用

Evaluation of Mirabegron Versus Tamsulosin or Their Combination in Treatment of Lower Urinary Tract Symptoms

NCT07307261Avraiem Talaat300

已完成

2 期

Comparison of Mirabegron, Tamsulosin and Solifenacin for relieving stent related symptoms.

CTRI/2019/02/017808Post Graduate Institute of Medical Education and Research120

尚未招募

3 期

A study to find out which is the better drug between tamsulosin and mirabegron in treating patients having ureteric stents for stent related urinary complaints

CTRI/2019/11/022115Dr Josef B Pachikara90

已完成

不适用

A Prospective Randomized Trial Comparing the Effects of Anti-reflux Versus Standard Ureteral Stents on Male Sexual Function

NCT07415993Rong Wang96

尚未招募

Phase 3 4

Comparing the Effects of Three meidicines Solifenacin, Tolterodine, and Fesoterodine in Patients with Ureteral Stents

CTRI/2025/03/082257Sanjay Gandhi Postgraduate Institute of Medical Sciences210